Pharmaceuticals

HIV ‘wonder drug’ may be made available on NHS in UK

18 Oct 2014

Pfizer’s anti-smoking drug Chantix to carry black-box waning till availability of study data

17 Oct 2014

Ranbaxy made to pay $40mn to settle pricing litigation in US

16 Oct 2014

AbbVie to reconsider $55-bn Shire deal

15 Oct 2014

AbbVie, the maker of top-selling arthritis drug Humira, plans to buy Shire to lower its US tax burden by moving its tax base to Ireland and to diversify its product line-up

Novartis fined Rs300 crore for overpricing painkiller Voveran

13 Oct 2014

Suven Life secures product patent in S Korea, US

13 Oct 2014

Valeant Pharmaceuticals plans to raise bid for Allergan

08 Oct 2014

Valeant is taking its takeover offer close to a December shareholder meeting where some of Allergan’s directors face removal

Cipla to invest Rs225 crore for setting up manufacturing unit in Iran

04 Oct 2014

Price cap on 108 “non-essential” drugs lifted as govt reverses stance

23 Sep 2014

Drug firms are now expected to jack up prices of a range of drugs used in the treatment of diseases from diabetes and cardio-vascular diseases to HIV/AIDS